Tickerplace logo

Tickerplace

GT Biopharma, Inc. logo

GTBPGT Biopharma, Inc.

GTBP Stock Price, Valuation & Chart | GT Biopharma, Inc.

Compare
$0.280-0.01 (-2.04%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyGTBP intrinsic valueGTBP calculated fair value vs price
OverviewFinancialsDividendsRatios

GTBP Historical price chart

GTBP Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization8.93M
PE Ratio-0.08
EPS-3.71
Trading Volume241.95K
Today's High/Low0.29/0.28
Dividend Yield0.00
52 Week High/Low1.37/0.26
Shares Outstanding31.55M
GTBP Financial Statement
GTBP Analyst ratings
GTBP Analysis & performance metrics

GTBP Company profile

GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary…

GTBP Management team

Management
Alan Louis Urban CPACFO
Chief Financial Officer & Secretary
Total 1 executive

GTBP Frequently asked questions

What is GT Biopharma, Inc. (GTBP) Stock Price?

Current stock price of GT Biopharma, Inc. (GTBP) stock is $0.280. The stock price is -2.04% lower in the session. The intraday range can be seen from this page. Volume of GT Biopharma, Inc. (GTBP) stock is 241.95K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the GT Biopharma, Inc. (GTBP) stock price going up or down today?

The stock price of GT Biopharma, Inc. (GTBP) can change with earnings, company news, and overall market sentiment. GT Biopharma, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the GT Biopharma, Inc. stock expensive at its current price?

Whether GT Biopharma, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GTBP on this page is -0.08. EPS on this page is -3.71. Compare those figures with peers and growth expectations before deciding if the current GT Biopharma, Inc. price is justified.

How has the stock price of GT Biopharma, Inc. (GTBP) performed historically?

Historical performance for GT Biopharma, Inc. (GTBP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GTBP reacted to past earnings and market events.

Should I buy GT Biopharma, Inc. (GTBP) stock, at this price?

Buying GT Biopharma, Inc. (GTBP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.